Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Regeneron Pharmaceuticals Stock (NASDAQ: REGN) stock price, news, charts, stock research, profile.
Open | $1.20K |
Close | $1.20K |
Volume / Avg. | 352.60K / 452.82K |
Day Range | $1.19K - $1.20K |
52 Wk Range | 769.19 - 1.20K |
Market Cap | $132.18B |
P/E Ratio | 31.47 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 75 |
Short Interest | 1.92% |
Days to Cover | 5.16 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Regeneron Pharmaceuticals (NASDAQ:REGN) through any online brokerage.
Other companies in Regeneron Pharmaceuticals’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Roivant Sciences (NASDAQ:ROIV).
Regeneron Pharmaceuticals has a consensus price target of $1051.79.
The stock price for Regeneron Pharmaceuticals (NASDAQ: REGN) is $1199.12 last updated August 23, 2024 at 4:37 PM EDT.
There are no upcoming dividends for Regeneron Pharmaceuticals.
Regeneron Pharmaceuticals’s Q3 earnings are confirmed for Thursday, October 31, 2024.
There is no upcoming split for Regeneron Pharmaceuticals.
Regeneron Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.